Differentiation between TTTS Stages I vs II and III vs IV does not affect probability of double survival after laser therapy
Authors: Bamberg C. , Diehl W. , Diemert A. , Sehner S. , Hecher K. 
Published: September 2020

Objective

To compare the perinatal outcome of monochorionic twin pregnancies with twin–twin transfusion syndrome (TTTS), according to the disease severity, defined using Quintero staging, after treatment with fetoscopic laser surgery.

Methods

This was a single‐center study of 1020 consecutive cases with severe TTTS, which were treated with fetoscopic laser surgery. During the study period from January 1995 to March 2013, the participants were included at a mean ± SD gestational age of 20.8 ± 2.2 weeks. Perinatal survival analysis, including the rates of double survival and survival of at least one fetus, was undertaken according to the Quintero staging system. For blockwise comparisons of data, the whole population was divided into five chronologically consecutive study subgroups of 200 patients in each of the first four subgroups and 220 in the last one.

Results

For the entire study population with known outcome (n = 1019), the rate of pregnancy with double fetal survival was 69.0% (127/184) in Stage‐I, 71.4% (257/360) in Stage‐II, 55.4% (236/426) in Stage‐III and 51.0% (25/49) in Stage‐IV TTTS cases. At least one twin survived in 91.3% (168/184) of pregnancies with Stage‐I, 89.7% (323/360) of those with Stage‐II, 83.1% (354/426) of those with Stage‐III and 77.6% (38/49) of those with Stage‐IV TTTS. The rates of double survival and survival of at least one fetus were both significantly higher in Stage‐II TTTS compared with those in Stage‐III TTTS cases (P < 0.001 and P = 0.011, respectively). Survival rates between pregnancies with Stage‐I vs Stage‐II TTTS and between those with Stage‐III vs Stage‐IV TTTS were not significantly different. Therefore, we combined pregnancies with Stage‐I or Stage‐II TTTS, and those with Stage‐III or Stage‐IV TTTS. The double survival rate was 70.6% (384/544) in combined Stage‐I and Stage‐II vs 54.9% (261/475) in combined Stage‐III and Stage‐IV TTTS cases (P < 0.001). At least one twin survived in 90.3% (491/544) of pregnancies with Stage‐I or Stage‐II TTTS vs 82.5% (392/475) in those with Stage‐III or Stage‐IV TTTS (P < 0.001). The double survival rate increased between the first and the last consecutive study subgroups from 59.8% (55/92) to 75.0% (96/128) (adjusted odds ratio (aOR)linear trend, 1.26 (95% CI, 1.01–1.56); P = 0.037) in pregnancies with Stage‐I or Stage‐II TTTS and from 41.7% (45/108) to 62.0% (57/92) (aORlinear trend, 1.21 (95% CI, 0.98–1.50); P = 0.082) in those with Stage‐III or Stage‐IV TTTS. Double survival rate was the lowest for Stage‐III cases in which the donor twin was affected by severely abnormal Doppler findings (45.4% (64/141)).

Conclusions

Double survival and survival of at least one fetus in monochorionic twin pregnancies with TTTS were related significantly to Quintero stage. However, our data show that the differentiation between Stages I vs II and Stages III vs IV does not have any significant prognostic implication for perinatal survival. © 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.